University of Cambridge clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-03 | NCT07913919 Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus Study | Recruiting |
Active trials by phase
| Phase 2 | 1 |
Not charted: 21 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 12
Diabetes (3) · Alzheimer's Disease (2) · Dementia (2) · Heart Disease (2) · Kidney Cancer (2) · Type 2 Diabetes (2) · Atrial Fibrillation (1) · Cystic Fibrosis (1) · Lung Cancer (1) · Lupus (SLE) (1)
Get alerts when University of Cambridge's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.